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Edited by S. KhorasanizadehAbstractLegend: Some ubiquitin-conjugating enzymes (E2s) com-
prise just the conserved core domain, whereas others such
as the UBE2E family have an N-terminal extension. Here,
we show that the core domain can build chains but the
N-terminal extension of this family is disordered and can
restrict formation of ubiquitin chains. This figure was
prepared using the coordinates for UBE2E1 (Protein Data
Bank ID: 3bzh).Protein ubiquitylation depends upon the concerted
action of ubiquitin-conjugating enzymes (E2s) and
ubiquitin ligases (E3s). All E2s have a conserved
ubiquitin-conjugating (UBC) domain but many have
variable extensions N- and C-terminal to the UBC
domain. For many E2s, the function of the extension
is not well understood. Here, we show that the
N-terminal extension of the UBE2E proteins regulates
formation of polyubiquitin chains by the processive
UBC domain. Target proteins are therefore mono-
ubiquitylated by full-length UBE2E, whereas the
UBC domain alone polyubiquitylates proteins.
Although the N-terminal extension of UBE2E1 is
largely disordered in solution, these residues have
a critical role in limiting chain building, and when
fused to the highly processive E2, UBE2D2,
ubiquitylation is limited. For some E2s, interaction
of ubiquitin with the ‘backside’ of the UBC domain
promotes polyubiquitylation. However, interaction of
ubiquitin with the backside of the UBC domain of
UBE2E1 does not appear to be important for
processivity. This study underscores the impor-
tance of studying full-length E2 proteins and not
just the highly conserved core domain.
© 2013 The Authors. Published by Elsevier Ltd.
Open access under CC BY-NC-SA license. Introduction
Protein ubiquitylation has a central role in deter-
mining protein abundance and in controlling protein
interactions. Addition of ubiquitin to substrate pro-thors. Published by Elsevier Ltd. Open access unteins depends on a cascade of conserved enzymes
[1]. First, the ubiquitin-activating enzyme (E1)
activates ubiquitin, resulting in formation of a
thioester link between the carboxyl group at the
C-terminus of ubiquitin and the catalytic cysteine inJ. Mol. Biol. (2013) 425, 4099–4111der CC BY-NC-SA license. 
4100 The N-terminal extension of UBE2E proteins limits chain formationthe E1. Ubiquitin is then transferred to the catalytic
cysteine of the ubiquitin-conjugating enzyme (E2).
The third step, which depends on the ubiquitin ligase
(E3), results in the formation of an isopeptide bond
between the C-terminus of ubiquitin and an amide
group, normally a lysine side chain, in the substrate
[2]. The hierarchical activity of these enzymes
serves to activate ubiquitin, to identify a substrate
protein, and to catalyze conjugation to the target.
Substrate proteins can be modified by a single
ubiquitin molecule (monoubiquitylation) or by the
addition of chains of linked ubiquitin molecules
(polyubiquitylation). Polyubiquitin chains are built
by the conjugation of one ubiquitin molecule (the
donor) to one of the seven lysine residues in the
ubiquitin molecule that has already been attached to
the substrate (the acceptor) [3]. The conformation of
the ubiquitin chain, as well as the consequence of
the modification, depends on the lysine residue that
links the ubiquitin molecules. E2s have a central role
in specifying the type of modification [4]. Humans
have ~35 E2s, with some E2s able to promote
attachment of the first ubiquitin molecule and to build
chains, whereas other E2s are only capable of either
initiation or chain elongation [4]. The molecular
interactions required for chain elongation are not
well understood, although several studies have
indicated that non-covalent interactions between
the E2 and ubiquitin are important [5,6]. In the case
of the promiscuous and widely studied UBE2D
family, interaction of ubiquitin with a non-covalent
binding site on the opposite side of the E2 to the
catalytic site (referred to as the ‘backside’), in-
creases chain formation [6,7]. More recently, a role
for interaction between the donor ubiquitin molecule
and the E2, UBE2S, has been proposed to promote
chain elongation [5]. In this case it is thought that the
donor ubiquitin is tethered so that nucleophilic attack
by Lys11 (K11) of the acceptor ubiquitin is favoured.
This interaction is weak, and could not be detected
by conventional approaches, yet the authors pro-
pose that non-covalent interaction of the E2 with
ubiquitin is a common feature of processive E2
enzymes.
E2 enzymes lie at the heart of the ubiquitylation
cascade and it is not surprising that all E2s have a
conserved core ubiquitin-conjugating (UBC) domain
of ~150 residues. This domain contains the catalytic
cysteine to which ubiquitin is attached, as well as
conserved features required for interaction with both
E1 and E3 proteins [8]. Some E2s have just the core
domain and these are referred to as Class I, while
others have extensions beyond the core domain [9].
Those with a C-terminal extension are referred to as
Class II, an N-terminal extension defines Class III
proteins, and those E2s with both N- and C-terminal
extensions belong to Class IV. For all E2s, the core
domain is essential for activity, but several studies
have suggested that the N- and C-terminal exten-sions can modulate ubiquitin transfer. In the case of
UBE2C (UbcH10), deletion of the N-terminus
resulted in more promiscuous ubiquitin transfer by
its cognate E3, APC (anaphase promoting complex),
leading to the inappropriate ubiquitylation and
destruction of substrate proteins [10]. For UBE2R1
(CDC34), the C-terminal extension is required for the
formation of polyubiquitin chains [11], and recent
studies suggest this may be due to interaction of the
C-terminal residues with the conjugated ubiquitin
molecule [12]. These studies highlight the impor-
tance of studying the intact E2 proteins, not just the
core domain.
Here, we have characterized the UBE2E family of
E2s that have an N-terminal extension [13]. The
three members of the UBE2E subfamily, UBE2E1,
UBE2E2, and UBE2E3, have a highly conserved
UBC domain (92% identity), but the N-terminal
extension is variable (Fig. 1a). Our results show
that the intrinsically disordered N-terminal extension
of UBE2E proteins limits formation of ubiquitin
chains. In our assays, the full-length UBE2E proteins
primarily promote protein monoubiquitylation,
whereas the core UBC domain of each can
efficiently build polyubiquitin chains.Results
The N-terminal extension of Class III E2s limits
ubiquitin transfer
To investigate the role of the N-terminal residues in
UBE2E1 (also known as UbcH6), we expressed and
purified full-length UBE2E1 (E2E1full) and the UBC
domain of UBE2E1 (E2E1core) (Fig. 1a and b).
Initially, the activity of the E2s was assessed with
cIAP2 (cellular inhibitor of apoptosis protein 2), an E3
ligase with a RING domain at its C-terminus [14,15].
We chose cIAP2 because a protein that comprises
the BIR3, ubiquitin-associated (UBA), CARD, and
RING domains (residues 255–604) is readily purified,
and it is autoubiquitylated when incubated with
UBE2E1 and UBE2D2, which have similar UBC
domains (Fig. S1a). To compare the activity of
different E2 proteins, we used purified proteins and
in vitro assays. Under comparable conditions,
E2E1core promoted extensive autoubiquitylation of
cIAP2, whereas E2E1full only promoted the addition
of one to two ubiquitin molecules to cIAP2 (Fig. 1c).
Although neither form of UBE2E1 was as active as
the highly processive UBE2D2, this result suggested
that the N-terminal residues in UBE2E1 limit cIAP2
autoubiquitylation.
To determine if reduced ubiquitin transfer by the
full-length protein depended on a specific interaction
with cIAP2, or if it was an intrinsic property of
UBE2E1, we also assessed ubiquitin transfer
Fig. 1. The N-terminal residues of UBE2E proteins restrict ubiquitin transfer. (a) Sequence alignment of human
UBE2E1, UBE2E2, and UBE2E3 generated using ClustalW. For the core domains, only sequence differences relative to
UBE2E1 are indicated. The start of the core constructs is indicated. (b) Schematic representation of the E2E1full, E2E1core,
and E2D2 proteins used in this study. (c) Autoubiquitylation of cIAP2 (residues 255-604) was used to compare the activity
of UBE2D2, E2E1full, and E2E1core. Purified cIAP2, E1, ubiquitin, and the indicated E2 were mixed in assay buffer and
incubated at 37 °C for the time indicated. Reactions were stopped by addition of Laemmli buffer and visualized by
Coomassie Blue staining. (d) E2E1full has a reduced ability to promote the autoubiquitylation of GST-cIAP2 RING,
GST-MDM2, and GST-CARP2. The assays were as described in (c) except an anti-ubiquitin antibody was used to
visualize the upper panel. (e) The activity of equivalent core and full-length versions of the related E2s, UBE2E2 and
UBE2E3, was also assessed by monitoring the autoubiquitylation of cIAP2.
4101The N-terminal extension of UBE2E proteins limits chain formationtogether with the E3s, MDM2 (mouse double minute
2) and CARP2 (caspase-8 and -10 associated RING
protein 2) (Fig. 1d). The RING domains of cIAP2,
MDM2, and CARP2, fused to glutathione S-transfer-
ase (GST), were used in assays because the isolated
RING domains exhibit limited autoubiquitylation, in
part due to the absence of lysine residues. GST has
26 lysine residues and the RING domains of MDM2and CARP2 promoted autoubiquitylation of the GST
fusion protein when incubated with E2E1core. How-
ever, as observed for cIAP2, the ladder due to the
addition of ubiquitin is diminished for E2E1full (Fig.
1d). Therefore, attachment of ubiquitin to target
proteins by UBE2E1 appears to be impeded.
UBE2E1 belongs to a subfamily of E2s that all
have a highly conserved UBC domain but variable
Fig. 2. UBE2E1 is a monomeric protein with a flexible N-terminal extension. (a) The structure of UBE2E1 (Protein Data
Bank ID: 3bzh) is shown as a ribbon, with onemolecule colored gray and the other colored cyan. The surface is also shown
for the gray molecule. The termini of each chain are indicated. (b) SEC-MALS analysis of E2E1full indicates that it is a
monomer (observed mass of 22.4 kDa; predicted mass of 21.4 kDa). A 300 μM sample of E2E1full was separated on a
24-mL S75 column coupled to a Wyatt Dawn 8+ detector (Wyatt Technology, Santa Barbara, CA). The refractive index
trace is shown (line) as well as the determined protein mass (boxes). The expected mass of the monomer and the dimer is
indicated by broken lines. (c) A similar analysis of E2E2full indicated that this protein is also a monomer. Determined
molecular mass of 23.8 kDa and predicted monomer mass of 22.25 kDa. (d) Analytical SEC analysis of E2E1full and
E2E1core. A sample of both E2E1full and E2E1core was applied to a 24-mL S75 column (GE Healthcare). The resulting
chromatogram, as well as that obtained from protein standards (GE Healthcare), is shown (bovine serum albumin of
67 kDa, ovalbumin of 43 kDa, chymotrypsinogen A of 25 kDa, ribonuclease A of 13.7 kDa) (see Fig. S3a). (e) CD spectra
of E2E1full (blue line) and E2E1core (black line). The spectra were recorded using an Olis DCM-10 spectrophotometer.
4102 The N-terminal extension of UBE2E proteins limits chain formationN-terminal extensions (Fig. 1a). To determine if the
N-terminal extension of the related E2s, UBE2E2
and UBE2E3, also modulated ubiquitin transfer, we
purified and characterized comparable core and
full-length proteins. For both UBE2E2 and UBE2E3,
the core UBC domain promoted the formation ofhigh-molecular-weight species that ran near the top
of the gel (Fig. 1e). In contrast, the ladders were
diminished when full-length UBE2E2 and UBE2E3
were included (Fig. 1e).
These results suggest that the highly conserved
UBE2E core domain is capable of promoting
4103The N-terminal extension of UBE2E proteins limits chain formationextensive ubiquitylation of target proteins. However,
the N-terminal extension of all three UBE2E proteins
limits efficient ubiquitin transfer.
Class III E2E proteins are monomeric
To understand the molecular basis of restricted
ubiquitin transfer by full-length UBE2E1, UBE2E2,
and UBE2E3, we initially analyzed the available
structures of full-length UBE2E1 and the core
domain of UBE2E2 [16]. The core UBC domains
of both UBE2E proteins are very similar (Fig. S2a),
and not surprisingly, they resemble other E2s, such
as UBE2D2 [16]. However, the structure of full-
length UBE2E1 (Fig. 2a) has two important
differences: (i) helix 1 (α1) is extended by two
turns, and (ii) residues 21–27, which are part of
the N-terminal extension, are resolved. Residues
21–27 interact with the side chains of Arg116,
Asn125, and Gln127, as well the C-terminal
carboxyl group of Thr193 on the β-sheet in the
UBC domain. As a consequence, the biological
unit for full-length UBE2E1 is reported to be a
dimer, with dimerization mediated by interaction of
residues 21–27 from one molecule with the core
domain of another molecule, as well as by contacts
between α1 of the two interacting molecules (Fig.
2a). In contrast, like other E2s, the UBC domain of
UBE2E2 is a monomer.
To characterize the oligomeric state of E2E1full
and E2E1core in solution, we analyzed the purified
proteins using size-exclusion chromatography
coupled to a multi-angle light scattering detector
(SEC-MALS). Both forms of UBE2E1 behaved as
monomers, with a calculated mass of 22.4 kDa for
E2E1full and 18.4 kDa for E2E1core, values that are
close to the expected masses of 21.4 kDa and
17.3 kDa, respectively (Fig. 2b and Fig. S2b).
Likewise, SEC-MALS analysis of purified E2E2fulland E2E2core indicated that both these proteins are
also monomeric (Fig. 2c and Fig. S2c). While the
mass of E2E1full and E2E1core differ by only 4 kDa,
when separated on a Superdex75 column, their
elution points are well resolved (Fig. 2d and Fig.
S2d). When protein mass is determined by reference
to protein standards, E2E2full elutes at a volume
expected for a dimer (~40 kDa), whereas E2E2core
elutes at a volume consistent with a monomer. It
seems likely that the early elution point of E2E1full,
combined with the crystal contacts, led the authors of
the crystal structure to propose that UBE2E1 exists
as a dimer. Our SEC-MALS data suggest this is
unlikely, and instead UBE2E1 is a monomer. This is
consistent with other E2s, such as UBE2K, which
have Stokes radii greater than expected for globular
proteins but have been shown to be monomers
[17,18].
The early elution of the full-length UBE2E proteins
from the size-exclusion column could be accounted
for by the presence of a disordered region in the
full-length proteins as the mass of non-globular
proteins, such as those that have regions of
extended structure, is often poorly predicted by
comparison to globular standard proteins [19]. In the
crystal structure of UBE2E1, most of the N-terminal
residues are missing, suggesting that they were
flexible (Fig. 2a) and analysis of the sequence using
IUPred indicates that they have features expected
for disordered regions (Fig. S2e) [20]. In support of
this, the N-terminal residues of UBE2E1 were
sensitive to proteolytic cleavage (data not shown),
and circular dichroism (CD) spectroscopy (Fig. 2e)
showed that the mean residue ellipticity for E2E1full
is decreased relative to E2E1core. Notably, the mean
residue ellipticity at 208 and 222 nM is reduced by
~20% in the E2E1full spectra, consistent with the
absence of regions of α-helical and β-sheet structure
in the 40 N-terminal residues.Fig. 3. The N-terminal extension
of UBE2E E2s limits ubiquitin chain
building. cIAP2 autoubiquitylation
assays were performed as de-
scribed in Fig. 1 except that either
WT- or K0-ubiquitin was used to
assess lysine-linked chain building.
Assays were incubated at 37 °C for
60 min. cIAP2 activity assays with
UBE2D2 were included as an activ-
ity control. Note that equal amounts
of K0- and WT-ubiquitin were in-
cluded in assays, but on these gels,
the K0-ubiquitin stacks as a tight
band, while the WT-ubiquitin band
is more diffuse.
4104 The N-terminal extension of UBE2E proteins limits chain formationTogether, these results suggest that the
N-terminal extension of UBE2E1 is intrinsically
disordered and does not serve to mediate E2
dimerization. As both E2E1full and E2E1core are
monomers in solution, it seems unlikely that the
oligomeric state of UBE2E1 accounts for the differ-
ence in ubiquitin transfer.Fig. 4. The N-terminal extension of UBE2E1 can limit ubiq
UBE2E1 was fused to UBE2D2. Autoubiquitylation assays wit
compare the activities of the proteins. Assays were performed
residues that limit ubiquitin transfer, we made a series of N-te
These proteins were purified to homogeneity and utilized in auto
anomalously when separated by SDS-PAGE.The N-terminal residues of Class III E2E proteins
limit chain building
To investigate the mechanism by which the
N-terminal residues limited ubiquitylation, we first
investigated if ubiquitin loading of the E2 was
impeded. Using a charging assay that measuresuitin transfer by UBE2D2. (a) The N-terminal extension of
h cIAP2 and the indicated E2 proteins were carried out to
as described in Fig. 1c using WT-ubiquitin. (b) To identify
rminal truncations as described in Materials and Methods.
ubiquitylation assays with cIAP2. Note that E2E1ΔN20 runs
4105The N-terminal extension of UBE2E proteins limits chain formationformation of the thioester linked E2~Ub conjugate,
we showed that E2E1full and E2E1core were both
efficiently charged with ubiquitin (Fig. S3a). Next, we
investigated whether the N-terminal extension of
UBE2E1 influenced either addition of the first
ubiquitin or ubiquitin chain building. To do this, we
compared cIAP2 autoubiquitylation with lysine-zero
(K0)-ubiquitin and wild-type (WT)-ubiquitin, for both
E2E1full and E2E1core. For E2E1core, the ladder
formed with K0-ubiquitin was considerably reduced
compared to that formed with WT-ubiquitin (Fig. 3,
left panel). In contrast, E2E1full promoted the
formation of comparable ladders with both WT- and
K0-ubiquitin, and these ladders are similar to those
formed by the core domain with K0-ubiquitin (Fig. 3,
right panel). This suggests that the N-terminal
residues primarily function to limit chain building by
UBE2E1. When RNF4 was used as the E3, the
activity of E2E1core was also significantly impeded
with K0-ubiquitin, whereas the activity of E2E1full
with K0- and WT-ubiquitin was similar (Fig. S3b).
To determine if the N-terminal residues of UBE2E2
and UBE2E3 also impeded polyubiquitylation, we
compared their activity with WT-ubiquitin and
K0-ubiquitin. As for UBE2E1, the ladders formed
by the core proteins were diminished when incubat-
ed with K0-ubiquitin, whereas modification by the
full-length proteins was comparable with both forms
of ubiquitin (Fig. S3c). Together, these results show
that the core domain of the UBE2E subfamily is
capable of promoting the formation of ubiquitin
chains. However, the full-length UBE2E proteins do
not efficiently promote formation of lysine-linked
ubiqui t in chains, and monoubiqui ty lat ion
predominates.
Characterization of the N-terminal residues
The N-terminal residues of UBE2C act indepen-
dently of the core domain to regulate ubiquitin
transfer, and when fused to UBE2D, they limited
the formation of higher-molecular-weight species
[10]. To investigate if the N-terminal residues of
UBE2E1 could also restrict chain formation inde-
pendently of the core domain, we created a chimeric
E2 by fusing the 37 N-terminal residues of UBE2E1
to the highly processive E2, UBE2D2 (E2D2–
NE2E1) (Fig. 4a). Following purification of E2D2–
NE2E1, autoubiquitylation of cIAP2 was assessed.
In assays with WT-ubiquitin, the ladder formed by
UBE2D2–NE2E1 was diminished compared to that
formed by UBE2D2 alone (Fig. 4a, left panel). In
contrast, the activity of the two proteins was more
comparable with K0-ubiquitin (Fig. 4b, right panel).
This suggests that similar to UBE2C, the N-terminal
residues of UBE2E1 can inhibit formation of poly-
ubiquitin chains by UBE2D2.
To identify residues within the N-terminal exten-
sion that restrict chain building, we generated twoadditional UBE2E1 deletion proteins, missing either
10 or 20 residues from the N-terminus, referred to as
E2E1ΔN10 and E2E1ΔN20, respectively. The identity
of these proteins was confirmed by mass spectrom-
etry before use in assays because E2E1ΔN20
migrated anomalously when analyzed by
SDS-PAGE (Fig. 4b). When cIAP2 autoubiquityla-
tion was measured, E2E1ΔN10 appeared to be
equivalent to E2E1full, with both E2s promoting
limited modification of cIAP2 (Fig. 4b). In contrast
E2E1ΔN20 promoted the formation of extended
chains and was more similar to E2E1core. This
suggested that the 10 most N-terminal residues do
not have a critical role in restricting ubiquitin transfer
by the core domain of UBE2E1. However, residues
10–20 are required to limit chain formation.
The N-terminal extensions of the three UBE2E
proteins are not highly conserved, and the extension
on UBE2E3 is slightly longer than that on UBE2E1
(Fig. 1a). Therefore, we generated a set of truncated
proteins for UBE2E3 and assessed their activity (Fig.
S4). When the 11 N-terminal residues were removed
to create E2E3ΔN11, ubiquitin transfer was compa-
rable to that of full-length UBE2E3. In contrast,
E2E3ΔN23 had an increased ability to promote cIAP2
autoubiquitylation and E2E3ΔN31 was comparable to
the core domain, with both promoting extensive
polyubiquitylation. This suggested that residues
11–31 of UBE2E3 prevent formation of ubiquitin
chains by the core domain of UBE2E3. The
sequences of the critical regions in UBE2E1 and
UBE2E3 differ but both are rich in Ser/Thr residues,
and it seems likely that they may have a critical role
in modulating chain building.
Chain building
Formation of polyubiquitin chains depends upon
the linkage of two ubiquitin molecules. For this to
occur, the acceptor ubiquitin must be in close
proximity to the catalytic site of the E2~Ub conjugate
so that one lysine, or a limited number of lysine
residues, are positioned for nucleophilic attack.
Although the molecular basis of chain formation is
not well understood, interactions between the
acceptor ubiquitin molecule and residues surround-
ing the active site of E2s appear to be important for
orienting the acceptor lysine so that chains of a
specific linkage form [5,21,22]. In addition, interac-
tion of ubiquitin with the backside β-sheet on the
opposite face of the E2 to the catalytic cysteine (Fig.
5a) is important for processivity of UBE2D proteins
[6]. When this interaction is disrupted, by mutation of
Ser22 to Arg (S22R) in UBE2D3, ubiquitin binding
and formation of ubiquitin chains are limited [6,7].
Likewise, disruption of the equivalent Sumo–Ubc9
interaction limits SUMO chain formation [23].
To understand the role of the backside binding site
in our system, we first characterized ubiquitin
Fig. 5 (legend on next page)
4106 The N-terminal extension of UBE2E proteins limits chain formation
4107The N-terminal extension of UBE2E proteins limits chain formationtransfer by cIAP2 and the well-characterized
UBE2D2 S22R mutant (UBE2D2S22R). With K0-
ubiquitin and UBE2D2, multiple ubiquitylated spe-
cies form, indicating that cIAP2 is multimonoubiqui-
tylated (Fig. 5b). To our surprise, although
disappearance of the parent cIAP2 band was
comparable, the ladder formed by UBE2D2S22R
and K0-ubiquitin was slightly diminished, suggesting
that UBE2D2S22R had a decreased ability to multi-
monoubiquitylate cIAP2. As reported by others [6,7],
with WT-ubiquitin, the UBE2D2S22R mutant had a
significantly reduced ability to form very high
molecular weight species that correspond to poly-
ubiquitylation of cIAP2 (Fig. 5c). This suggests that
in the context of cIAP2, disruption of ubiquitin binding
to the backside of UBE2D2 limits both multimonou-
biquitylation and polyubiquitylation.
To investigate if a similar interaction is important
for formation of ubiquitin chains by the core
domain of UBE2E1, we mutated the equivalent
residue, Ser68, to arginine in the core domain of
UBE2E1 (E2E1core-S68R). When protein monoubi-
quitylation was assessed using K0-ubiquitin,
E2E1core and E2E1core-S68R appeared equivalent
(Fig. 5d). In addition, with WT-ubiquitin, E2E1core
and E2E1core-S68R promoted the formation of
similar ladders (Fig. 5e). This suggests that
neither mono- nor polyubiquitylation of cIAP2 is
reduced by mutation of Ser68 in E2E1core.
The backsides of UBE2E1 and UBE2D2 are
similar, and 8 of the 12 contact residues are
identical, but these results suggest that they are
not functionally equivalent. It seems likely that either
ubiquitin does not interact with the β-sheet of
UBE2E1, or the serine is not essential for binding
ubiquitin. In support of the former, Brzovic et al.
noted that they did not detect binding of ubiquitin to
UBE2E1, and when we evaluated binding of
ubiquitin to E2E1core using NMR conditions compa-
rable to those used previously [6], no interaction was
detected (data not shown). Together, these results
suggest that the molecular basis for polyubiquityla-
tion by UBE2E1 and UBE2D2 differs, and the
conserved serine that is present on the backside of
many E2s does not have a critical role in UBE2E1. In
addition, our results suggest that the backside
interaction in UBE2D2 both multimonoubiquitylation
and polyubiquitylation of cIAP2.Fig. 5. Contribution of the backside ubiquitin binding site to u
(3GBZ) onto the structure of UBE2D2~Ub conjugate (Protein D
one molecule, shown as a ribbon (teal) and a surface, and th
shown as a gray ribbon. The side chains of Ser22 (UBE2
Comparison of initial ubiquitin transfer for UBE2D2 (E2D2) and
as described in Fig. 1c except that K0-ubiquitin was included in
was used, allowing the chain-building capacity of UBE2D2 (E
compared. (d) The initial rate of ubiquitin transfer by E2E1core (E
analyzed in a similar manner. (e) Likewise, chain building wasDiscussion
The precise pairing of E2 and E3 determines the
type of ubiquitin modification each target protein
receives. However, our understanding of ubiquitin
transfer is limited, and given an E2–E3 pair, in most
cases, it is not possible to predict how the target
protein will be modified. In addition to the conserved
α/β fold UBC domain that defines this class of
proteins [8], many E2s have N- and C-terminal
extensions [9]. The role of each extension appears to
differ. In the case of UBE2C, the N-terminal
extension limits polyubiquitylation and is required
for correct substrate selection [10], while the
C-terminal extension of UBE2K, which contains a
UBA, increases processivity [24,25]. Here, we show
that the conserved core domain of the UBE2E family
(UBE2E1, UBE2E2, and UBE2E3) can build ubiqui-
tin chains, but the N-terminal extension prevents this
activity. As a consequence, the full-length UBE2E
proteins preferentially monoubiquitylate substrate
proteins, whereas the core UBC domain polyubiqui-
tylates them. This observation is likely to be of broad
significance because the UBE2E proteins are
thought to be hub E2s that interact with a large
number of E3 ligases [26].
The UBC domain from UBE2E proteins is con-
served (92% sequence identity) and resembles the
UBC of other E2 proteins [16]. In contrast, although
the sequence of the N-terminal extension of each
UBE2E is highly conserved across a range of
species, there is considerable variation between
the three proteins, and the extension varies between
37 and 52 amino acids in length. However, the
N-terminal residues of UBE2E1 are intrinsically
disordered [27], and for all three UBE2E proteins, a
disordered structure is predicted. Recent evidence
suggests that the acidic C-terminal extension of the
UBE2R (CDC34) E2s is also intrinsically disordered
[12,28], and it is likely that other E2s will have
regions of disorder.
Disordered regions are prevalent at the termini of
proteins where they have a range of functions,
including preventing protein aggregation and medi-
ating protein–protein interactions [29]. Conforma-
tionally flexible regions, such as the N-terminal
residues in UBE2E proteins, offer advantages to
proteins because they can bind to multiple targetsbiquitin transfer. (a) Overlay of the core domain of UBE2E1
ata Bank ID: 3A33). The interaction between ubiquitin from
e backside of UBE2D2 (teal ribbon) is shown. UBE2E1 is
D2) and Ser68 (UBE2E1) are shown as red sticks. (b)
the backside mutant (E2D2 S22R). Assays were performed
the assay. (c) Assays are as in (b) except that WT-ubiquitin
2D2) and the backside binding mutant (E2D2 S22R) to be
2E1 core) and the backside mutant (E2E1 core S68R) was
assessed using WT-ubiquitin.
4108 The N-terminal extension of UBE2E proteins limits chain formationand they have a large capture area [30]. These
features may be advantageous to E2s because
ubiquitin–E2 interactions are weak, and multiple
conformations can be adopted and, in fact, are
required for the assembly of ubiquitin chains with
different linkages [31]. Therefore, the flexible nature
of the N-terminal residues in UBE2E proteins may
allow these resides to inhibit the acceptor ubiquitin
molecule from binding at multiple sites on the core
domain. More generally, the ability of the disordered
regions of E2s to inhibit the formation of ubiquitin
chains is consistent with a recent study that
highlighted an important role for intrinsically disor-
dered regions in mediating autoinhibition [32,33].
For all three UBE2E proteins, deletion studies
indicate that the N-terminal extension can limit
ubiquitin chain building. Indeed, as reported for
UBE2C [10], fusion of the N-terminal extension of
UBE2E1 onto UBE2D2 limits chain building. The
molecular features that distinguish E2s that mono-
ubiquitylate substrates, and those with chain-building
properties, are not well understood [4,34]. However,
residues surrounding the active site of the E2 have
been shown to influence donor–acceptor ubiquitin
interactions and influence the chain linkage. For
example, mutation of residues surrounding the
active site of UBE2R1 and UBE2D1 has been
shown to influence chain formation [22,35]. In the
case of UBE2D1, it preferentially forms mostly
K11-linked chains, but mutation of a single residue
near the active site from serine to alanine (Ser83Ala)
increases formation of K63-linked chains [22]. This
indicates that the position of the acceptor ubiquitin
plays an important role in specifying the ubiquitin
chain linkage. In a similar manner, non-covalent
interactions between UBE2S and the donor ubiqui-
tin molecule orient the acceptor ubiquitin molecule
so that formation of K11-linked chains is promoted
[5]. It is therefore possible that the N-terminal
extension of UBE2E proteins prevents chain build-
ing by restricting the donor ubiquitin molecule from
accessing the acceptor ubiquitin at the E2 active
site. The nature of this interaction is uncertain and it
will be important to determine if sequence-specific
features play an important role, or if just a stretch of
disordered residues that have the properties of an
‘entropic bristle’ are sufficient to inhibit formation of
ubiquitin chains [36]. Further studies will be required
to define the molecular basis for inhibiting chain
extension.
Ubiquitin also interacts with the β-sheet of some
E2s (Fig. 5a) [8]. For the UBE2D proteins, the
non-covalent interaction between ubiquitin and the
backside binding site of the E2 has been well
characterized, and disruption of this interaction by
introduction of a mutation (S22R) limits ubiquitin
chain formation on target proteins [6,7,37]. These
studies did not report any changes in substrate
monoubiquitylation, and it had been thought thatbackside binding promoted chain formation by
increasing the local concentration of E2~Ub conju-
gate. However, in the case of cIAP2, which is subject
to extensive multimonoubiquitylation, both multi-
monoubiquitylation and polyubiquitylation are slo-
wed upon disruption of ubiquitin binding to the
backside of UBE2D2 (Fig. 5b and c). This suggests
that the first ubiquitin attached to cIAP2 may be able
to recruit a UBE2D2~Ub conjugate and thereby
enhance attachment of subsequent ubiquitin mole-
cules. We therefore propose that interaction of
ubiquitin with the backside of UBE2D proteins may
act more generally to increase the efficiency of
ubiquitin transfer, as opposed to only enhancing
ubiquitin chain formation.
TheUBCdomain of theUBE2E proteins is similar to
the UBE2D family (64% sequence identity, 86%
similarity) and both families promote the multimonou-
biquitylation and polyubiquitylation of cIAP2. Howev-
er, we could not detect an interaction between
ubiquitin and UBE2E1, andmutation of the conserved
serine residue in the backside of the core domain does
not impede ubiquitin transfer. In fact cIAP2 autoubi-
quitylation by the UBC domain of UBE2E1 was
comparable to that of UBE2D2 that carries a mutation
on its backside ubiquitin-binding site. These observa-
tions suggest that the backside of UBE2E1 is not a
critical determinant of ubiquitin transfer and this may
account for the decreased processivity of the UBC
domain compared to UBE2D2.
The N-terminal extensions of the UBE2E family
possess a number of serine residues and are
intrinsically disordered, properties often associated
with post-translational modification and it is possible
that in a cellular setting, the function of the N-terminal
residues could be modulated by modification. Many
proteins, including E2s, are acetylated at the
N-terminus and this can modulate protein function
[38]. Notably, acetylation of the Nedd8 E2, UBC12
(UBE2M), promotes interaction with the Nedd8-E3
DCN1, and as a consequence, neddylation of
Cullin1 is increased [39,40]. Acetylation of the
SUMO E2 Ubc9 (UBE2I) has also been shown to
modulate target preference [41]. Whether the
N-terminal extension of UBE2E1 is modified remains
an open question; however, these studies highlight
how E2 activity can be tuned in unexpected ways by
post-translational modifications.
The behavior of E2s besides the widely studied
UBE2D family is required to develop a detailed
understanding of the ‘ubiquitin code’. Our analysis
of the UBE2E proteins reveals an unexpected level
of regulation by the N-terminal residues and
highlights the importance of studying the full-length
E2 proteins. Future efforts will focus on under-
standing the molecular mechanisms by which the
core domain of UBE2E proteins can promote chain
formation and how this can be inhibited by the
N-terminal residues.
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Protein constructs and cloning
The E3s used in this study include a truncated form of
cIAP2 that includes the BIR3, CARD, UBA, and RING
domains (residues 255–604) (accession Q13489) [14,15],
as well as the RING domains of cIAP2 (residues 536–605),
MDM2 (accession Q00987, residues 417–491), and
CARP2 (accession Q8WZ73, residues 319–363). The
E2s used include full-length UBE2D2 (accession P62837),
UBE2E1 (accession P51965), UBE2E2 (accession
Q96LR5), and UBE2E3 (accession Q969T4), as well as
the core forms of UBE2E1 (UBE2E1core: residues 38–
193), UBE2E2 (UBE2E2core: residues 47–201), and
UBE2E3 (E2E3core: residues 53–207), and other trunca-
tions as indicated; for example, E2E1ΔN10 is a truncated
form of E2E1 that lacks the 10 N-terminal residues. All
proteins were expressed as GST fusions, and after
removal of the N-terminal tag, the following residues
remain N-terminal to the E2 protein: GPLSGT. In the early
forms of UBE2E1, the purified proteins contained a
C-terminal extension of eight residues as a consequence
of cloning. These residues were removed in later con-
structs and shown not to alter activity. Some E2 proteins
were also expressed with a C-terminal hexahistidine tag; in
these constructs, the extra residues LEHHHHHH are
present C-terminal to the E2. The UBE2D2–UBE2E1
N-terminal residue fusion protein was generated using
blunt-end cloning. Residues 1–46 of UBE2E1 precede
UBE2D2, and Met1 of UBE2D2 is not coded for. Mutants
were generated using QuikChange mutagenesis and
confirmed by sequencing.
Protein expression and purification
All proteins were over-expressed in Escherichia coli
BL21(DE3). Untagged yeast E1 (accession P20973) was
expressed using auto-induction conditions [42]. The cells
were lysed in 50 mMTris, pH 8, and the cleared supernatant
was bound, in the presence of ATP and MgCl2, to ubiquitin
affinity resin, and following washing, purified E1 was eluted
byadditionof 5 mMDTT.Untaggedubiquitin and lysine zero
(K0)-ubiquitin were expressed and purified as previously
described [43]. Briefly, following cell lysis, ubiquitin was
purified from the clarified lysate using a cation-exchange
column equilibrated at pH 4.5. Ubiquitin was eluted from the
column at ~350 mM NaCl and the eluted fractions contain-
ing ubiquitin were purified further by SEC.
E3 proteins were expressed at 18 °C for 16 h following
addition of 0.1 mM IPTG. Cells were harvested by
centrifugation and lysed by sonication. GST-tagged pro-
teins were purified initially by batch affinity chromatogra-
phy to glutathione Sepharose. The GST-tag was then
removed using PreScission protease and the soluble E3
was purified by SEC using either a Superdex75 or
Superdex200 column (GE Healthcare) that had been
equilibrated in 1× phosphate-buffered saline (PBS). 6×
His-tagged proteins were bound to nickel-charged 1-mL
IMAC columns (GE Healthcare) and eluted by an
increasing concentration of imidazole. These proteins
were further purified using a Superdex75 column (GE
Healthcare) in 1× PBS.SEC-MALS analysis
Purified protein at a concentration of 300 μM was applied
to a Superdex75 HR 10/30 column (GE Healthcare)
equilibrated in 1× PBS that was coupled in line with a
MALS detector (Wyatt Technology). Refractive index and
light scattering were measured and the data were analyzed
usingASTRAVsoftwareafter calibrationwith abovineserum
albumin standard. The molecular mass of the monomer
was determined using the ProtParam online tool [44].
Analytical SEC
Protein standards A–D (67 kDa, 43 kDa, 25 kDa, and
13.7 kDa) were applied to a Superdex75 HR 10/30 column
equilibrated in 1× PBS. The column void volume was
determined by the elution volume of a b200-kDa protein.
The void volume was subtracted from the elution volume of
the protein standard and plotted against log10 of the
molecular mass of the known standards, generating a
linear curve. The molecular mass of unknown proteins was
then estimated based on their elution volume.
Circular dichroism
The far-UV spectra of UBE2E1 proteins were recorded
using an Olis DCM-10 CD Spectrophotometer and a
1 mm quartz cuvette at 20 °C. Protein samples at a
concentration of 50 μM in 20 mM Na phosphate,
pH 7.5, and 25 mM NaCl were analyzed. Measurements
were recorded at 1 nm intervals with a 3 s integration
time. For each sample, the scan shown represents an
average of three scans after subtraction of the
buffer-only measurement.
Ubiquitylation assays
Ubiquitylation assays were performed with purified
protein components. The final concentration of each
protein was as follows: E1 at 5 nM, E2 at 5 μM, E3 at
5 μM, and Ub at ~50 μM. Assay reactions also contained
20 mM Tris–HCl, pH 7.5, 50 mM NaCl, 20 mM MgCl2,
5 mM ATP, and 2 mM DTT and were incubated at 37 °C
for the time indicated. Samples were rotated if resin-bound
protein was present to ensure mixing of assay compo-
nents. Reactions were stopped by the addition of 4×
Laemmli buffer and analyzed by Coomassie staining after
separation by SDS-PAGE or when indicated following gel
transfer and immunoblotting.Acknowledgements
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CARP2, caspase-8 and -10 associated RING protein 2;
cIAP2, cellular inhibitor of apoptosis protein 2; E1, ubiquitin-
activating enzyme; E2, ubiquitin-conjugating enzyme; E3,
ubiquitin ligase; GST, glutathione S-transferase; K0, lysine-
zero; MALS, multi-angle light scattering; MDM2, mouse
double minute 2; PBS, phosphate-buffered saline; SEC,
size-exclusion chromatography; UBC domain, ubiquitin-
conjugating domain; UBA domain, ubiquitin-associated
domain; WT, wild type.References
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